Nabriva Therapeutics AG(NBRV)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NBRV Nabriva Therapeutics AG

交易中 12-19 10:59:58 EST

1.42

+0.00

0.00%

最高1.42	最低1.42	成交量0.00
今开1.42	昨收1.42	日振幅0.00%
总市值454.61万	流通市值426.99万	总股本320.15万
成交额0.00	换手率0.00%	流通股本300.70万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NBRV","market":"US","secType":"STK","nameCN":"Nabriva Therapeutics AG","latestPrice":1.42,"timestamp":1734623998857,"preClose":1.42,"halted":0,"volume":0,"delay":0,"floatShares":3007007,"shares":3201495,"eps":-18.67952,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"12-19 10:59:58 EST","open":1.42,"high":1.42,"low":1.42,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.67952,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734642000000},"adr":0,"listingDate":1442548800000,"adjPreClose":1.42,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/NBRV/wiki","defaultTab":"wiki","newsList":[{"id":"2355898009","title":"Nabriva Therapeutics Plc盘中异动 急速上涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2355898009","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2355898009?lang=zh_cn&edition=full","pubTime":"2023-07-31 21:30","pubTimestamp":1690810248,"startTime":"0","endTime":"0","summary":"北京时间2023年07月31日21时30分，Nabriva Therapeutics Plc股票出现异动，股价大幅拉升5.63%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Allarity Therapeutics Inc、Better Therapeutics Inc涨幅较大，Allarity Therapeutics Inc、60 Degrees Pharmaceuticals Inc、Nabriva Therapeutics Plc较为活跃，换手率分别为679.91%、8.69%、7.91%，振幅较大的相关个股有Apollomics Inc、Bionomics Ltd Ads Each Rep 180 Ord Shs、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为9.93%、9.42%、6.78%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023073121304882e55ec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023073121304882e55ec2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NBRV","NBRVF"],"gpt_icon":0},{"id":"2353023116","title":"Nabriva Therapeutics Plc盘中异动 股价大跌8.00%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2353023116","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2353023116?lang=zh_cn&edition=full","pubTime":"2023-07-21 01:29","pubTimestamp":1689874152,"startTime":"0","endTime":"0","summary":"北京时间2023年07月21日01时29分，Nabriva Therapeutics Plc股票出现异动，股价快速下跌8.00%。截至发稿，该股报1.58美元/股，成交量4461股，换手率0.14%，振幅0.58%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.62%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家临床阶段的生物制药公司。Nabriva 从事新型抗感染药物的研发，以治疗严重感染，重点是截短侧耳素类抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023072101291282e1569a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023072101291282e1569a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NBRV"],"gpt_icon":0},{"id":"2352726064","title":"Nabriva Therapeutics Plc盘中异动 快速上涨7.36%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2352726064","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2352726064?lang=zh_cn&edition=full","pubTime":"2023-07-19 02:37","pubTimestamp":1689705421,"startTime":"0","endTime":"0","summary":"北京时间2023年07月19日02时37分，Nabriva Therapeutics Plc股票出现异动，股价大幅拉升7.36%。截至发稿，该股报1.75美元/股，成交量6730股，换手率0.21%，振幅10.82%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.14%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家临床阶段的生物制药公司。Nabriva 从事新型抗感染药物的研发，以治疗严重感染，重点是截短侧耳素类抗生素。XENLETA 旨在抑制细菌核糖体上特定蛋白质的合成。该公司拥有两种获批产品 SIVEXTRO 和 XENLETA 以及一种开发候选产品 CONTEPO 的商业权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230719023701823e6d6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230719023701823e6d6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2350119159","title":"Nabriva Therapeutics Plc盘中异动 早盘快速拉升5.42%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2350119159","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2350119159?lang=zh_cn&edition=full","pubTime":"2023-07-10 21:43","pubTimestamp":1688996581,"startTime":"0","endTime":"0","summary":"北京时间2023年07月10日21时43分，Nabriva Therapeutics Plc股票出现波动，股价快速拉升5.42%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.28%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家临床阶段的生物制药公司。Nabriva 从事新型抗感染药物的研发，以治疗严重感染，重点是截短侧耳素类抗生素。XENLETA 旨在抑制细菌核糖体上特定蛋白质的合成。该公司拥有两种获批产品 SIVEXTRO 和 XENLETA 以及一种开发候选产品 CONTEPO 的商业权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202307102143018224b5d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202307102143018224b5d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2346685697","title":"Nabriva Therapeutics Plc盘中异动 急速下跌5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2346685697","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2346685697?lang=zh_cn&edition=full","pubTime":"2023-06-27 22:04","pubTimestamp":1687874686,"startTime":"0","endTime":"0","summary":"北京时间2023年06月27日22时04分，Nabriva Therapeutics Plc股票出现波动，股价快速下挫5.89%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体跌幅为1.16%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家临床阶段的生物制药公司。Nabriva 从事新型抗感染药物的研发，以治疗严重感染，重点是截短侧耳素类抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023062722044684734cb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023062722044684734cb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2343903770","title":"Nabriva Therapeutics Plc盘中异动 快速上涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2343903770","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2343903770?lang=zh_cn&edition=full","pubTime":"2023-06-16 00:35","pubTimestamp":1686846911,"startTime":"0","endTime":"0","summary":"北京时间2023年06月16日00时35分，Nabriva Therapeutics Plc股票出现异动，股价急速拉升6.12%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Revelation Biosciences Inc C/Wts 10/01/2027 、Io Biotech Inc涨幅较大，Polarityte Inc、Fresh Tracks Therapeutics Inc、Oncosec Medical Incorporated较为活跃，换手率分别为105.24%、63.06%、54.68%，振幅较大的相关个股有Biocardia Inc C/Wts 06/08/2024、Axcella Health Inc、Apexigen Inc C/Wts 29/07/2027 ，振幅分别为56.28%、45.72%、45.25%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家处于临床研发阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023061600351282d354ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023061600351282d354ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2342355495","title":"Nabriva Therapeutics Plc盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2342355495","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2342355495?lang=zh_cn&edition=full","pubTime":"2023-06-10 03:58","pubTimestamp":1686340700,"startTime":"0","endTime":"0","summary":"北京时间2023年06月10日03时58分，Nabriva Therapeutics Plc股票出现波动，股价急速跳水5.36%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.40%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家处于临床研发阶段的生物制药公司。消息层面，截至03时58分，Nabriva Therapeutics Plc股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202306100358208369b86d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202306100358208369b86d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2341319808","title":"Nabriva Therapeutics Plc盘中异动 早盘快速上涨5.56%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2341319808","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2341319808?lang=zh_cn&edition=full","pubTime":"2023-06-07 21:30","pubTimestamp":1686144633,"startTime":"0","endTime":"0","summary":"北京时间2023年06月07日21时30分，Nabriva Therapeutics Plc股票出现异动，股价急速拉升5.56%。截至发稿，该股报1.52美元/股，成交量305股，换手率0.01%，振幅0.00%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.40%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家处于临床研发阶段的生物制药公司。该公司致力于研究和开发治疗严重感染的新型抗感染药物，着眼于研制截短侧耳素类的抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202306072130348368cbc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202306072130348368cbc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2341309078","title":"Nabriva Therapeutics Plc盘中异动 早盘股价大涨11.64%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2341309078","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2341309078?lang=zh_cn&edition=full","pubTime":"2023-06-05 22:36","pubTimestamp":1685975802,"startTime":"0","endTime":"0","summary":"北京时间2023年06月05日22时36分，Nabriva Therapeutics Plc股票出现异动，股价大幅上涨11.64%。截至发稿，该股报1.63美元/股，成交量2269股，换手率0.07%，振幅5.62%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.37%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家处于临床研发阶段的生物制药公司。该公司致力于研究和开发治疗严重感染的新型抗感染药物，着眼于研制截短侧耳素类的抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202306052236438066eaf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202306052236438066eaf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2340974650","title":"Nabriva Therapeutics Plc盘中异动 早盘股价大跌6.75%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2340974650","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2340974650?lang=zh_cn&edition=full","pubTime":"2023-06-02 22:43","pubTimestamp":1685717026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230602224346836723c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230602224346836723c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2338091121","title":"Nabriva Therapeutics Plc盘中异动 快速跳水5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2338091121","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2338091121?lang=zh_cn&edition=full","pubTime":"2023-05-27 00:58","pubTimestamp":1685120316,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305270058368364d47e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305270058368364d47e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2338519613","title":"Nabriva Therapeutics Plc盘中异动 股价大涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2338519613","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2338519613?lang=zh_cn&edition=full","pubTime":"2023-05-25 21:30","pubTimestamp":1685021449,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052521304983648335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052521304983648335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2337809673","title":"Nabriva Therapeutics Plc盘中异动 早盘股价大跌6.15%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2337809673","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2337809673?lang=zh_cn&edition=full","pubTime":"2023-05-22 22:59","pubTimestamp":1684767554,"startTime":"0","endTime":"0","summary":"北京时间2023年05月22日22时59分，Nabriva Therapeutics Plc股票出现波动，股价大幅跳水6.15%。截至发稿，该股报1.83美元/股，成交量4706股，换手率0.15%，振幅4.62%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.28%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家处于临床研发阶段的生物制药公司。该公司致力于研究和开发治疗严重感染的新型抗感染药物，着眼于研制截短侧耳素类的抗生素。消息层面，截至22时59分，Nabriva Therapeutics Plc股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052222591480660b4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052222591480660b4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2336203548","title":"Nabriva Therapeutics Plc盘中异动 早盘急速拉升7.23%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2336203548","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2336203548?lang=zh_cn&edition=full","pubTime":"2023-05-19 21:31","pubTimestamp":1684503080,"startTime":"0","endTime":"0","summary":"北京时间2023年05月19日21时31分，Nabriva Therapeutics Plc股票出现波动，股价快速拉升7.23%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Novabay Pharmaceuticals Inc、180 Life Sciences Corp、Zyversa Therapeutics Inc涨幅较大，Novabay Pharmaceuticals Inc、180 Life Sciences Corp、Enveric Biosciences Inc较为活跃，换手率分别为277.43%、38.42%、31.17%，振幅较大的相关个股有Neximmune Inc、Oculis Holding Ag C/Wts 06/03/2028 、Athersys Inc，振幅分别为13.33%、11.83%、11.30%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家处于临床研发阶段的生物制药公司。消息层面，截至21时31分，Nabriva","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305192131208236225b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305192131208236225b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NBRV"],"gpt_icon":0},{"id":"2336149833","title":"Nabriva Therapeutics Plc盘中异动 早盘大幅上涨6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2336149833","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2336149833?lang=zh_cn&edition=full","pubTime":"2023-05-17 23:24","pubTimestamp":1684337050,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051723241083624588&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051723241083624588&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2335143896","title":"Nabriva Therapeutics Plc盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2335143896","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2335143896?lang=zh_cn&edition=full","pubTime":"2023-05-15 22:11","pubTimestamp":1684159916,"startTime":"0","endTime":"0","summary":"北京时间2023年05月15日22时11分，Nabriva Therapeutics Plc股票出现波动，股价大幅下跌5.23%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Xenetic Biosciences Inc C/Wts 19/07/2024 、Greenlight Biosciences Holdings Pbc C/Wts 02/02/2027 、Oramed Pharmaceuticals Inc涨幅较大，Dermata Therapeutics Inc、Jaguar Health Inc、Oramed Pharmaceuticals Inc较为活跃，换手率分别为75.41%、23.67%、22.38%，振幅较大的相关个股有Zivo Bioscience Inc C/Wts 02/06/2026 、Oramed Pharmaceuticals Inc、Trevena Inc，振幅分别为58.18%、34.98%、25.19%。Nabriva Therapeutics Plc公司简介：Nabriva Th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051522115782c91a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051522115782c91a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NBRV"],"gpt_icon":0},{"id":"2334512222","title":"Nabriva Therapeutics Plc盘中异动 股价大跌6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2334512222","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2334512222?lang=zh_cn&edition=full","pubTime":"2023-05-09 03:38","pubTimestamp":1683574712,"startTime":"0","endTime":"0","summary":"北京时间2023年05月09日03时38分，Nabriva Therapeutics Plc股票出现波动，股价急速下跌6.98%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.10%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家处于临床研发阶段的生物制药公司。该公司致力于研究和开发治疗严重感染的新型抗感染药物，着眼于研制截短侧耳素类的抗生素。该公司正在开发的候选产品lefamulin是第一种可给人体全身用药的截短侧耳素类抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230509033832835ffb82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230509033832835ffb82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2327655124","title":"Nabriva Therapeutics Plc盘中异动 早盘大幅下跌7.06%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2327655124","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2327655124?lang=zh_cn&edition=full","pubTime":"2023-04-14 21:32","pubTimestamp":1681479143,"startTime":"0","endTime":"0","summary":"北京时间2023年04月14日21时32分，Nabriva Therapeutics Plc股票出现异动，股价大幅下挫7.06%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Processa Pharmaceuticals Inc、Evelo Biosciences Inc、Mind Medicine  Inc涨幅较大，Altamira Therapeutics Ltd、Fate Therapeutics、Panbela Therapeutics Inc较为活跃，换手率分别为%、%、%，振幅较大的相关个股有Vascular Biogenics Ltd、Evelo Biosciences Inc、Vyant Bio Inc，振幅分别为%、%、%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家处于临床研发阶段的生物制药公司。消息层面，截至21时32分，Nabriva Therapeutics Plc股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230414213224827a8e68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230414213224827a8e68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2327524641","title":"Nabriva Therapeutics Plc盘中异动 下午盘股价大涨5.23%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2327524641","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2327524641?lang=zh_cn&edition=full","pubTime":"2023-04-14 01:20","pubTimestamp":1681406410,"startTime":"0","endTime":"0","summary":"北京时间2023年04月14日01时20分，Nabriva Therapeutics Plc股票出现异动，股价急速拉升5.23%。截至发稿，该股报1.61美元/股，成交量8343股，换手率0.27%，振幅5.88%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.81%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家处于临床研发阶段的生物制药公司。该公司致力于研究和开发治疗严重感染的新型抗感染药物，着眼于研制截短侧耳素类的抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202304140120108062af75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202304140120108062af75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0},{"id":"2326661835","title":"Nabriva Therapeutics Plc股价重挫13.71% 市值跌63.44万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2326661835","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2326661835?lang=zh_cn&edition=full","pubTime":"2023-04-10 21:32","pubTimestamp":1681133532,"startTime":"0","endTime":"0","summary":"北京时间2023年04月10日21时32分，Nabriva Therapeutics Plc股票出现异动，股价快速下跌13.71%。截至发稿，该股报1.51美元/股，成交量462股，换手率0.02%，振幅0.00%。Nabriva Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.67%。Nabriva Therapeutics Plc公司简介：Nabriva Therapeutics PLC 是一家处于临床研发阶段的生物制药公司。该公司致力于研究和开发治疗严重感染的新型抗感染药物，着眼于研制截短侧耳素类的抗生素。该公司正在开发的候选产品lefamulin是第一种可给人体全身用药的截短侧耳素类抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023041021321282785a08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023041021321282785a08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBRV","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nabriva.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nabriva Therapeutics plc于2005年10月在奥地利成立。2017年3月1日，该公司在爱尔兰注册成立。该公司是一家临床阶段的生物制药公司,从事研发新型抗感染药物开发以用于治疗严重感染，主要研发对截短侧耳素类的抗生素。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":3.292201},{"month":2,"riseRate":0.5,"avgChangeRate":0.028852},{"month":3,"riseRate":0.25,"avgChangeRate":-0.082491},{"month":4,"riseRate":0.25,"avgChangeRate":-0.034637},{"month":5,"riseRate":0.125,"avgChangeRate":0.003587},{"month":6,"riseRate":0.25,"avgChangeRate":-0.091634},{"month":7,"riseRate":0.25,"avgChangeRate":-0.031551},{"month":8,"riseRate":0,"avgChangeRate":-0.099453},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.097117},{"month":10,"riseRate":0.25,"avgChangeRate":-0.072138},{"month":11,"riseRate":0.5,"avgChangeRate":-0.089536},{"month":12,"riseRate":0.125,"avgChangeRate":-0.206994}],"exchange":"NASDAQ","name":"Nabriva Therapeutics AG","nameEN":"Nabriva Therapeutics AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nabriva Therapeutics AG(NBRV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nabriva Therapeutics AG(NBRV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nabriva Therapeutics AG,NBRV,Nabriva Therapeutics AG股票,Nabriva Therapeutics AG股票老虎,Nabriva Therapeutics AG股票老虎国际,Nabriva Therapeutics AG行情,Nabriva Therapeutics AG股票行情,Nabriva Therapeutics AG股价,Nabriva Therapeutics AG股市,Nabriva Therapeutics AG股票价格,Nabriva Therapeutics AG股票交易,Nabriva Therapeutics AG股票购买,Nabriva Therapeutics AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nabriva Therapeutics AG(NBRV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nabriva Therapeutics AG(NBRV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况